Samsung, Celltrion to exhibit at J.P. Morgan Healthcare Conference
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
Labcorp to Participate in J.P. Morgan Healthcare Conference
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your
Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference
Biomedicines ("Generate") today announced that Mike Nally, Chief Executive Officer, will provide an update on the company's platform, which combines generative AI and experimental innovation, and its advancing pipeline at the 43rd Annual J.
Ensem Therapeutics Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Ensem Therapeutics, Inc. (ENSEM), a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble® platform to advance
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling
Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 30 days following the presentation.
ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced that Chairman and Chief Executive Officer, David Hallal,
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
About Recludix Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets. The company’s management team includes industry veterans with a track record of success,
M&A, obesity top of mind for investors at J.P. Morgan Healthcare conference: Portal Innovations CEO
John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...
Nvidia In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...
Morningstar4d
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 43rd annual J.P. Morgan Healthcare Conference on January 13, 2025. The live presentation ...
Business Wire4d
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025
today announced that members of its management team will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. The company’s formal presentation will begin at 10:30 a ...
Modern Healthcare3d
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...